反応式
[CH3:1][N:2]1[C:8](=[O:9])[C:7]2[CH:10]=[CH:11][CH:12]=[CH:13][C:6]=2[N:5]2[CH:14]=[N:15][C:16]([C:17]([O:19][CH2:20]C)=[O:18])=[C:4]2[CH2:3]1.[C-]#N.[K+]>CO>[CH3:1][N:2]1[C:8](=[O:9])[C:7]2[CH:10]=[CH:11][CH:12]=[CH:13][C:6]=2[N:5]2[CH:14]=[N:15][C:16]([C:17]([O:19][CH3:20])=[O:18])=[C:4]2[CH2:3]1参加物
4
実験手順
285 mg (1 mmol) of ethyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate and 66 mg of potassium cyanide are heated to boiling under reflux for 24 hours in 10 ml of methanol. Then, the mixture is concentrated on a rotary evaporator, the residue is partitioned between water and chloroform, extracted twice with chloroform, the chloroform phase is dried over magnesium sulphate and evaporated. There is obtained methyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate of melting point 212°-214° C. This product is uniform according to thin-layer chromatography.
後処理
- concentrationThen, the mixture is concentrated on a rotary evaporator
- customthe residue is partitioned between water and chloroform
- extractionextracted twice with chloroform
- dry with materialthe chloroform phase is dried over magnesium sulphate
- customevaporated
出典と根拠
- ORDレコード
- ord-2343817238154b91a71b7b1a643bedcf
- 出典データセット
- uspto-grants-1982_08
- 特許番号
- US04346030
関連ノート
読み込み中…